Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Nicotinic receptor modulation to treat alcohol and drug dependence.

Rahman S, Engleman EA, Bell RL.

Front Neurosci. 2015 Jan 15;8:426. doi: 10.3389/fnins.2014.00426. eCollection 2014. Review.

2.

Behavioral mechanisms underlying nicotine reinforcement.

Rupprecht LE, Smith TT, Schassburger RL, Buffalari DM, Sved AF, Donny EC.

Curr Top Behav Neurosci. 2015;24:19-53. doi: 10.1007/978-3-319-13482-6_2. Review.

3.

Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.

Jupp B, Dalley JW.

Br J Pharmacol. 2014 Oct;171(20):4729-66. doi: 10.1111/bph.12787. Epub 2014 Sep 5. Review.

4.

Protection genes in nucleus accumbens shell affect vulnerability to nicotine self-administration across isogenic strains of adolescent rat.

Chen H, Luo R, Gong S, Matta SG, Sharp BM.

PLoS One. 2014 Jan 22;9(1):e86214. doi: 10.1371/journal.pone.0086214. eCollection 2014.

5.

Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.

Liu X.

Int J Neuropsychopharmacol. 2014 Jan;17(1):105-16. doi: 10.1017/S1461145713000874. Epub 2013 Aug 19.

6.

Rats are the smart choice: Rationale for a renewed focus on rats in behavioral genetics.

Parker CC, Chen H, Flagel SB, Geurts AM, Richards JB, Robinson TE, Solberg Woods LC, Palmer AA.

Neuropharmacology. 2014 Jan;76 Pt B:250-8. doi: 10.1016/j.neuropharm.2013.05.047. Epub 2013 Jun 18.

7.

Potential therapeutic uses of mecamylamine and its stereoisomers.

Nickell JR, Grinevich VP, Siripurapu KB, Smith AM, Dwoskin LP.

Pharmacol Biochem Behav. 2013 Jul;108:28-43. doi: 10.1016/j.pbb.2013.04.005. Epub 2013 Apr 18. Review.

8.

Impact of tobacco regulation on animal research: new perspectives and opportunities.

Donny EC, Taylor TG, LeSage MG, Levin M, Buffalari DM, Joel D, Sved AF.

Nicotine Tob Res. 2012 Nov;14(11):1319-38. doi: 10.1093/ntr/nts162. Epub 2012 Sep 4. Review.

9.

Role of nicotinic acetylcholine receptors in the effects of cocaine-paired contextual stimuli on impulsive decision making in rats.

Xie X, Arguello AA, Reittinger AM, Wells AM, Fuchs RA.

Psychopharmacology (Berl). 2012 Oct;223(3):271-9. doi: 10.1007/s00213-012-2715-z. Epub 2012 Apr 20.

10.

Denicotinized versus average nicotine tobacco cigarette smoking differentially releases striatal dopamine.

Domino EF, Ni L, Domino JS, Yang W, Evans C, Guthrie S, Wang H, Koeppe RA, Zubieta JK.

Nicotine Tob Res. 2013 Jan;15(1):11-21. doi: 10.1093/ntr/nts029. Epub 2012 Apr 5.

11.

Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.

Panlilio LV, Justinova Z, Mascia P, Pistis M, Luchicchi A, Lecca S, Barnes C, Redhi GH, Adair J, Heishman SJ, Yasar S, Aliczki M, Haller J, Goldberg SR.

Neuropsychopharmacology. 2012 Jul;37(8):1838-47. doi: 10.1038/npp.2012.31. Epub 2012 Mar 28.

12.
13.

Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats.

Liu X, Jernigen C, Gharib M, Booth S, Caggiula AR, Sved AF.

Behav Pharmacol. 2010 Mar;21(2):153-60. doi: 10.1097/FBP.0b013e328337be95.

14.

Nicotinic receptor-based therapeutics and candidates for smoking cessation.

Dwoskin LP, Smith AM, Wooters TE, Zhang Z, Crooks PA, Bardo MT.

Biochem Pharmacol. 2009 Oct 1;78(7):732-43. doi: 10.1016/j.bcp.2009.06.002. Epub 2009 Jun 10. Review.

15.

The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking.

Nair SG, Adams-Deutsch T, Epstein DH, Shaham Y.

Prog Neurobiol. 2009 Sep;89(1):18-45. doi: 10.1016/j.pneurobio.2009.05.003. Epub 2009 Jun 2. Review.

16.

Effects of nicotine in experimental animals and humans: an update on addictive properties.

Le Foll B, Goldberg SR.

Handb Exp Pharmacol. 2009;(192):335-67. doi: 10.1007/978-3-540-69248-5_12. Review.

17.

Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.

Dwoskin LP, Pivavarchyk M, Joyce BM, Neugebauer NM, Zheng G, Zhang Z, Bardo MT, Crooks PA.

Nebr Symp Motiv. 2009;55:31-63. No abstract available.

18.

The motivation to obtain nicotine-conditioned reinforcers depends on nicotine dose.

Palmatier MI, Coddington SB, Liu X, Donny EC, Caggiula AR, Sved AF.

Neuropharmacology. 2008 Dec;55(8):1425-30. doi: 10.1016/j.neuropharm.2008.09.002. Epub 2008 Sep 17.

19.

Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats.

Liu X, Palmatier MI, Caggiula AR, Sved AF, Donny EC, Gharib M, Booth S.

Psychopharmacology (Berl). 2009 Mar;202(4):589-98. doi: 10.1007/s00213-008-1335-0. Epub 2008 Sep 21.

20.

mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats.

Gass JT, Osborne MP, Watson NL, Brown JL, Olive MF.

Neuropsychopharmacology. 2009 Mar;34(4):820-33. doi: 10.1038/npp.2008.140. Epub 2008 Sep 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk